News and Events »

Check back regularly for latest news and events from PREDICT Consortium.


Saturday, February 1st, 2014 | 0 Comments
Exome sequencing of tumor specimens is an important component of the PREDICT Consortium’s quest to identify determinants of drug response in renal cancer. Sequenza is a state-of-the-art software to determine tumor copy number profiles directly from matched tumor/normal exome sequencing data. Sequenza read more »


Saturday, February 1st, 2014 | 0 Comments
It is likely that the complex repertoire of somatic and germ-line genomic anomalies complement each other and what amounts to a driver event depends on the constellation of passenger events that are also present in the cancer genome. The purpose of PrediGO read more »

October 2013

Tuesday, October 29th, 2013 | 0 Comments
Invited Lecture, Charles Swanton, Lelund Chung Lecture Basic Urologic Research Meeting, Tennessee, USA read more »

November 2012

Thursday, November 29th, 2012 | 0 Comments
Invited Lecture, Charles Swanton, Geoffrey Beene Symposium, Memorial Sloan-Kettering Cancer Center “Cancer Heterogeneity” read more »

Dr. James Larkin to give keynote speech at the Norwegian “Cancer Crosslinks Meeting” 2013 in Oslo

Monday, October 29th, 2012 | 0 Comments
Dr. James Larkin from the Royal Marsden Hospital, a partner in the Predict project, is to give a keynote speech at the Norwegian “Cancer Crosslinks Meeting”, on January 17th 2013 in Oslo. “Cancer Crosslinks” is an annual event designed to establish a platform read more »

Fast Breaking: PREDICT Consortium paper achieves higher citation increase than any other paper in Clinical Medicine

Saturday, October 27th, 2012 | 0 Comments
Thomson Reuters Web of Science, the company that also publishes the Impact Factor for scientific journals, has identified the article by Gerlinger et al. “Intratumor heterogeneity and branched evolution revealed by multiregion sequencing” as a Fast Breaking Paper in Clinical Medicine. This read more »

PREDICT presents results at ESMO and AACR 2013

Monday, September 10th, 2012 | 0 Comments
PREDICT Consortium results lead to invitation to discuss results at the Plenary session presentation at ESMO 2013 and the Ruth Sager Memorial Symposium at AACR 2013 read more »

Intratumour heterogeneity

Thursday, March 8th, 2012 | 0 Comments
London – A paper published in the March edition of the New England Journal of Medicine, based on patient data from the E-PREDICT consortium, shows just how complex tumours can be. Researchers in London used a range of techniques, including next-generation sequencing, read more »

Ocelot: A new website for renal cancer researchers

Thursday, October 20th, 2011 | 0 Comments
COPENHAGEN — The PREDICT Consortium announced today the availability of a new web-based resource for researchers in renal cancer. The “OCELOT-Renal” website enables scientists to easily explore the behavior of a chosen gene in various genomic data sets representing renal cell carcinoma. read more »

American Society of Clinical Oncology (ASCO) Trials in Progress June 2011 Chicago meeting

Friday, May 20th, 2011 | 0 Comments
The PREDICT Consortium Approach to Biomarker Discovery in Renal Cell Carcinoma J Clin Oncol 29: 2011 (suppl; abstr TPS179) read more »